• Jan

  22

  Research in Progress Seminar Series

  12:00 PM - 1:30 PM

  Jan

  24

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Jan

  31

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Feb

  7

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• Feb

  14

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Feb

  21

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Feb

  26

  Research in Progress Seminar Series

  12:00 PM - 1:30 PM

  Feb

  28

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• Mar

  7

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Mar

  14

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Mar

  21

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Mar

  28

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• Apr

  4

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Apr

  11

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Apr

  18

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

  Apr

  25

  Neurology Department Grand Rounds

  7:30 AM - 8:30 AM

• "Neuro-oncology research in Nigeria: a great untapped potential".

  Adekanmbi A, Peters KB, Razis E, Adeolu AA, Lukas RV, Balogun JA.

  World Neurosurg. 2019 Jan 16. pii: S1878-8750(19)30066-X. doi: 10.1016/j.wneu.2018.12.192. [Epub ahead of print]

• MIR93 (microRNA -93) Regulates Tumorigenicity and Therapy Response of Glioblastoma by Targeting Autophagy.

  Huang T, Wan X, Alvarez AA, James CD, Song X, Yang Y, Sastry N, Nakano I, Sulman EP, Hu B, Cheng SY.

  Autophagy. 2019 Jan 18. doi: 10.1080/15548627.2019.1569947. [Epub ahead of print]

• Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1.

  Hu YS, Do J, Edamakanti CR, Kini AR, Martina M, Stupp SI, Opal P.

  Brain. 2019 Jan 14. doi: 10.1093/brain/awy328. [Epub ahead of print]

• 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice.

  Lazic D, Sagare AP, Nikolakopoulou AM, Griffin JH, Vassar R, Zlokovic BV.

  J Exp Med. 2019 Jan 15. pii: jem.20181035. doi: 10.1084/jem.20181035. [Epub ahead of print]

• Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase.

  Zheng J, Jeon S, Jiang W, Burbulla LF, Ysselstein D, Oevel K, Krainc D, Silverman RB.

  J Med Chem. 2019 Jan 15. doi: 10.1021/acs.jmedchem.8b01294. [Epub ahead of print]

• Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.

  Burt RK,… Balabanov R …

  JAMA. 2019 Jan 15;321(2):165-174. doi: 10.1001/jama.2018.18743.

• Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.

  Gadgeel SM,… Lukas RV …

  Lung Cancer. 2019 Feb;128:105-112. doi: 10.1016/j.lungcan.2018.12.017. Epub 2018 Dec 19.

• Late-onset neutropenia following ocrelizumab therapy for multiple sclerosis.

  Cohen BA.

  Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006924. doi: 10.1212/WNL.0000000000006924. [Epub ahead of print] No abstract available.

• BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification.

  Kan C, Ding N, Yang J, Tan Z, McGuire TL, Lu H, Zhang K, Berger DMP, Kessler JA, Kan L.

  Stem Cell Res Ther. 2019 Jan 11;10(1):14. doi: 10.1186/s13287-018-1107-7.

View full list in PubMed